Gout Clinical Trials

REduCing Immunogenicity to PegloticasE (RECIPE) Study

Condition:   Gout Chronic
Interventions:   Drug: Pegloticase 8 MG/ML [Krystexxa];   Drug: Placebo;   Drug: Mycophenolate Mofetil
Sponsors:   University of Alabama at Birmingham;   University of Michigan
Not yet recruiting

Learn More

D-0120 Safety and PK/PD Study in Healthy Volunteers

Condition:   Gout
Intervention:   Drug: D-0120
Sponsor:   InventisBio Inc.

Learn More

Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid

Conditions:   Gout Chronic;   Hyperuricemia
Interventions:   Drug: SEL-212;   Drug: SEL-037;   Drug: SVP-rapamycin (SEL-110)
Sponsor:   Selecta Biosciences, Inc.

Learn More

Novel Methods for Ascertainment of Gout Flares -A Pilot Study

Condition:   Gout
Interventions:   Device: IVR (Phone call);   Device: RheumPro (Smartphone application)
Sponsors:   University of Alabama at Birmingham;   University of Nebraska

Learn More

1-4 of 4
Results per page

Join the community!

You must be a member of healtheo360 in order to view this group

Register with Email Address

Already a member? Click here to login

healtheo360 believes strongly in user privacy.